Recent Quotes

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		-0.320		-0.230		0.0900
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
AVDL	Avadel Pharmaceuticals	7.85	0.00	0%		459.1M

Avadel Pharmaceuticals Frequently Asked Questions

How do I buy Avadel Pharmaceuticals (AVDL) stock?

You can purchase shares of Avadel Pharmaceuticals (NASDAQ: AVDL) through any online brokerage.

View our list of the best stock brokerages.

Who are Avadel Pharmaceuticals's (AVDL) competitors?

Other companies in Avadel Pharmaceuticals’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Aerie Pharmaceuticals (NASDAQ:AERI), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and BioDelivery Sciences Intl (NASDAQ:BDSI).

What is the target price for Avadel Pharmaceuticals (AVDL) stock?

The latest price target for Avadel Pharmaceuticals (NASDAQ: AVDL) was reported by HC Wainwright & Co. on March 10, 2021. The analyst firm set a price target for 17.00 expecting AVDL to rise to within 12 months (a possible 116.56% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Avadel Pharmaceuticals (AVDL)?

The stock price for Avadel Pharmaceuticals (NASDAQ: AVDL) is $7.85 last updated Thu Jun 17 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Avadel Pharmaceuticals (AVDL) pay a dividend?

There are no upcoming dividends for Avadel Pharmaceuticals.

When is Avadel Pharmaceuticals (NASDAQ:AVDL) reporting earnings?

Avadel Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Avadel Pharmaceuticals (AVDL) going to split?

There is no upcoming split for Avadel Pharmaceuticals.

What sector and industry does Avadel Pharmaceuticals (AVDL) operate in?

Avadel Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.